AMICUS THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
AMICUS THERAPEUTICS, INC. had Operating Lease Right-of-Use Assets of $21.14 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-20
- 2025-12-31: Operating Lease, Right-of-Use Asset $21.14M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $21.55M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $21.99M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $22.14M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $21.14M 10-K · filed 2026-02-20 |
| 2025-09-30 | $21.55M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $21.99M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $22.14M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $22.28M 10-K · filed 2026-02-20 |
| 2024-09-30 | $23.14M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $22.61M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $23.00M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $26.31M 10-K · filed 2025-02-19 |
| 2023-09-30 | $29.51M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $28.04M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $28.48M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $29.53M 10-K · filed 2024-02-28 |
| 2022-09-30 | $29.87M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $30.45M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $27.51M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $20.59M 10-K · filed 2023-03-01 |
| 2021-09-30 | $21.27M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $22.03M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $22.36M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $23.30M 10-K · filed 2022-02-24 |
| 2020-09-30 | $23.40M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $23.95M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $32.50M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $33.31M 10-K · filed 2021-03-01 |
| 2019-09-30 | $35.81M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $35.05M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $36.21M 10-Q · filed 2019-05-09 |